Eiko Lifesciences Ltd Q4FY22 and Year Ended result : PAT surges down by 2.09% to ₹0.7 Cr in FY22-21

Net Profit of ₹0.16 crore in the quarter ended on March 31, 2022 as against ₹0.37 crore in the corresponding quarter ended in last year on Mar 31, 2021. The PAT surges down by 55.67%.

logo ctedit- eiko lifesciences (the company)
article continues after this advertisement

Eiko Lifesciences Limited operates as an investment company. Eiko invests, acquires, sells, transfers, subscribes, and holds shares, bonds, stocks, and obligations. The company reported its Q4FY22 and year ended financial results on 22 April, 2022; the details are as below :

(I) Audited Consolidated Financial Results for Quarter Ended (YoY comparison):

The company has reported, a consolidated Total Income of ₹5.49 crore in the quarter ended on March 31, 2022 as against ₹6.28 crore in the corresponding quarter ended last year on Mar 31, 2021, decreased by 12.49%.

The company has posted a consolidated Net Profit of ₹0.16 crore in the quarter ended on March 31, 2022 as against ₹0.37 crore in the corresponding quarter ended in last year on Mar 31, 2021. The PAT surges down by 55.67%.

The status of the EPS of the company stood at ₹0.18 as on March 31, 2022 compared to the previous quarter ended on Mar 31, 2021 which was ₹0.93, down by 80.65%.

₹*Mar 31, 2022Dec 31, 21Mar 31, 21
Total Income5.495.726.28
Total Expenses5.305.805.79
PBT /(Loss)0.19(0.07)0.48
PAT /(Loss)0.16(0.08)0.37
*figures are in Crores

(II) Audited Consolidated Financial Result details for the Year Ended :

The company has reported, a consolidated Total Income of ₹26.08 crore in the financial year ended on March 31, 2022 as against ₹12.45 crore for the financial year ended on Mar 31, 2021, increased by 109.51%.

The company has posted a consolidated Net Profit of ₹0.68 crore in the financial year ended on March 31, 2022 as against ₹0.70 crore for the financial year ended on March 31, 2021. The PAT surges down by 2.09%.

The status of the EPS of the company stood at ₹0.9 as on March 31, 2022 compared to the previous year ended on March 31, 2021 which was ₹1.61, down by 44.10%.

₹*Mar 31, 2022 (FY22)Mar 31, 2021 (FY21)
Total Income26.0812.45
Total Expenses25.1411.61
PBT /(Loss)0.940.83
PAT /(Loss)0.680.70
*figures are in Crores

Shares of Eiko Lifesciences Ltd was last traded in BSE at ₹46.35 as compared to the previous close of ₹48.35. The total number of shares traded during the day was 4614 in over 31 trades.

The stock last hit in BSE,

  • Intraday High of ₹ 49.00
  • Intraday low of ₹ 45.95